Tokyo Tape
Sign in
← MedPeer

Half-year report · Q2

6095.TEDINET S100VQUM
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥6.3bn2024-10-01 → 2025-03-31Cons.Net sales
Revenue¥14.9bn2023-10-01 → 2024-09-30Cons.Net sales (5-year summary)
Revenue¥7.9bn2023-10-01 → 2024-03-31Cons.Net sales
Operating income¥629m2024-10-01 → 2025-03-31Cons.Operating income
Operating income¥836m2023-10-01 → 2024-03-31Cons.Operating income
Ordinary income¥654m2024-10-01 → 2025-03-31Cons.Ordinary income
Ordinary income¥1.3bn2023-10-01 → 2024-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥831m2023-10-01 → 2024-03-31Cons.Ordinary income
Profit before tax¥654m2024-10-01 → 2025-03-31Cons.Income before income taxes
Profit before tax¥550m2023-10-01 → 2024-03-31Cons.Income before income taxes
Net income (owners)¥427m2024-10-01 → 2025-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.5bn2023-10-01 → 2024-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥199m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income¥427m2024-10-01 → 2025-03-31Cons.Profit loss
Net income¥213m2023-10-01 → 2024-03-31Cons.Profit loss
Total assets¥14.8bnat 2025-03-31Cons.Assets
Total assets¥15.6bnat 2024-09-30Cons.Assets
Total assets¥14.9bnat 2024-03-31Cons.Total assets (5-year summary)
Total liabilities¥5.0bnat 2025-03-31Cons.Liabilities
Total liabilities¥6.1bnat 2024-09-30Cons.Liabilities
Net assets / equity¥9.8bnat 2025-03-31Cons.Net assets
Net assets / equity¥9.5bnat 2024-09-30Cons.Net assets
Net assets / equity¥8.7bnat 2024-03-31Cons.Net assets (5-year summary)
Cash and deposits¥7.2bnat 2025-03-31Cons.Cash and deposits
Cash and deposits¥7.3bnat 2024-09-30Cons.Cash and deposits
Cash & equivalents¥7.2bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥7.3bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.4bnat 2023-09-30dCons.Cash and cash equivalents
Operating cash flow¥149m2024-10-01 → 2025-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.9bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥807m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Investing cash flow¥93m2024-10-01 → 2025-03-31Cons.Net cash provided by used in investment activities
Investing cash flow¥1.3bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥47m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥360m2024-10-01 → 2025-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.3bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥378m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥19.652024-10-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.262023-10-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.182023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio66.1%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.7%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio56.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 43
SegmentItemPeriodValue
Otherother segmentsrevenue2024-10-01 → 2025-03-31¥123m
Otherother segmentsrevenue external2024-10-01 → 2025-03-31¥123m
Otherother segmentssegment profit2024-10-01 → 2025-03-31−¥6m
Reconciling Itemsreconcilingrevenue2024-10-01 → 2025-03-31−¥74m
Reconciling Itemsreconcilingrevenue intersegment2024-10-01 → 2025-03-31−¥74m
Reconciling Itemsreconcilingsegment profit2024-10-01 → 2025-03-31−¥683m
jpcrp040300-q2r_E30650-000Doctor Platformreportable segmentrevenue2024-10-01 → 2025-03-31¥2.0bn
jpcrp040300-q2r_E30650-000Doctor Platformreportable segmentrevenue external2024-10-01 → 2025-03-31¥2.0bn
jpcrp040300-q2r_E30650-000Doctor Platformreportable segmentrevenue intersegment2024-10-01 → 2025-03-31¥2m
jpcrp040300-q2r_E30650-000Doctor Platformreportable segmentsegment profit2024-10-01 → 2025-03-31¥964m
jpcrp040300-q2r_E30650-000Marketing Supportreportable segmentrevenue2024-10-01 → 2025-03-31¥4.1bn
jpcrp040300-q2r_E30650-000Marketing Supportreportable segmentrevenue external2024-10-01 → 2025-03-31¥4.1bn
jpcrp040300-q2r_E30650-000Marketing Supportreportable segmentrevenue intersegment2024-10-01 → 2025-03-31¥72m
jpcrp040300-q2r_E30650-000Marketing Supportreportable segmentsegment profit2024-10-01 → 2025-03-31¥393m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2024-10-01 → 2025-03-31¥166m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2024-10-01 → 2025-03-31¥166m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2024-10-01 → 2025-03-31−¥38m
—segment totalrevenue2024-10-01 → 2025-03-31¥6.3bn
—segment totalrevenue external2024-10-01 → 2025-03-31¥6.2bn
—segment totalrevenue intersegment2024-10-01 → 2025-03-31¥74m
—segment totalsegment profit2024-10-01 → 2025-03-31¥1.3bn
Otherother segmentsrevenue2023-10-01 → 2024-03-31¥1.2bn
Otherother segmentsrevenue external2023-10-01 → 2024-03-31¥1.2bn
Otherother segmentsrevenue intersegment2023-10-01 → 2024-03-31¥419,000
Otherother segmentssegment profit2023-10-01 → 2024-03-31¥159m
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥23m
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥23m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥679m
jpcrp040300-q2r_E30650-000Doctor Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥2.0bn
jpcrp040300-q2r_E30650-000Doctor Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥2.0bn
jpcrp040300-q2r_E30650-000Doctor Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥13m
jpcrp040300-q2r_E30650-000Doctor Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥967m
jpcrp040300-q2r_E30650-000Marketing Supportreportable segmentrevenue2023-10-01 → 2024-03-31¥4.4bn
jpcrp040300-q2r_E30650-000Marketing Supportreportable segmentrevenue external2023-10-01 → 2024-03-31¥4.4bn
jpcrp040300-q2r_E30650-000Marketing Supportreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥10m
jpcrp040300-q2r_E30650-000Marketing Supportreportable segmentsegment profit2023-10-01 → 2024-03-31¥520m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2023-10-01 → 2024-03-31−¥131m
—segment totalrevenue2023-10-01 → 2024-03-31¥6.7bn
—segment totalrevenue external2023-10-01 → 2024-03-31¥6.6bn
—segment totalrevenue intersegment2023-10-01 → 2024-03-31¥23m
—segment totalsegment profit2023-10-01 → 2024-03-31¥1.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 515
ItemContextValueUnit
Operating incomePrior1YTDDuration835994000JPY
Operating incomeCurrentYTDDuration629439000JPY
Interest income noiPrior1YTDDuration54000JPY
Interest income noiCurrentYTDDuration3407000JPY
Equity in earnings of affiliates noiPrior1YTDDuration27815000JPY
Equity in earnings of affiliates noiCurrentYTDDuration33928000JPY
Insurance income noiPrior1YTDDuration5003000JPY
Insurance income noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration758000JPY
Other noiCurrentYTDDuration9397000JPY
Non operating incomePrior1YTDDuration33632000JPY
Non operating incomeCurrentYTDDuration46733000JPY
Interest expenses noePrior1YTDDuration6208000JPY
Interest expenses noeCurrentYTDDuration10617000JPY
Loss on retirement of noncurrent assets noePrior1YTDDuration10621000JPY
Loss on retirement of noncurrent assets noeCurrentYTDDuration1408000JPY
Compensation expenses noePrior1YTDDuration21384000JPY
Compensation expenses noeCurrentYTDDuration7650000JPY
Other noePrior1YTDDuration138000JPY
Other noeCurrentYTDDuration2160000JPY
Non operating expensesPrior1YTDDuration38352000JPY
Non operating expensesCurrentYTDDuration21836000JPY
Ordinary incomePrior1YTDDuration831274000JPY
Ordinary incomeCurrentYTDDuration654336000JPY
Impairment loss elPrior1YTDDuration281519000JPY
Impairment loss elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration281519000JPY
Extraordinary lossCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration549755000JPY
Income before income taxesCurrentYTDDuration654336000JPY
Income taxes currentPrior1YTDDuration307881000JPY
Income taxes currentCurrentYTDDuration264447000JPY
Income taxes deferredPrior1YTDDuration28418000JPY
Income taxes deferredCurrentYTDDuration-36843000JPY
Income taxesPrior1YTDDuration336299000JPY
Income taxesCurrentYTDDuration227603000JPY
Profit lossPrior1YTDDuration213455000JPY
Profit lossCurrentYTDDuration426732000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration14177000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Profit loss attributable to owners of parentPrior1YTDDuration199278000JPY
Profit loss attributable to owners of parentCurrentYTDDuration426732000JPY
Profit lossPrior1YTDDuration213455000JPY
Profit lossCurrentYTDDuration426732000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-379000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration7654000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-423000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-511000JPY
Other comprehensive incomePrior1YTDDuration-803000JPY
Other comprehensive incomeCurrentYTDDuration7142000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-09-30pass
balance sheet identityconsolidated 2025-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-10-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2024-10-01/2025-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2024-10-01/2025-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass